Evidence map›Paper›PMID 18490578›Full record

ArticleArchives of otolaryngology--head & neck surgery2008

Examination of oral cancer biomarkers by tissue microarray analysis.

Peter Choi, C Diana Jordan, Eduardo Mendez, John Houck, Bevan Yueh, D Gregory Farwell, Neal Futran, Chu Chen

Open access · greenAbstract read
In one paragraph

Article in Archives of otolaryngology--head & neck surgery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Pseudogenes: A Novel Source of Trans-Acting Antisense RNAs.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Peter ChoiDepartment of Otolaryngology-Head and Neck Surgery, University ofWashington, Seattle, WA, USA.
C Diana Jordan
Eduardo Mendez
John Houck
Bevan Yueh
D Gregory Farwell
Neal Futran
Chu Chen
University of Washington · USFred Hutch Cancer Center · USUniversity of California, Davis · USUniversity of Minnesota · US

Funding

Research Training in OtolaryngologyT32DC000018 · NIDCD · UNIVERSITY OF WASHINGTON · PI STONE, JENNIFER S. · 1989 to 2023
$7.8M
ORAL CANCER: MOLECULAR PROFILES &CLINICAL OUTCOMESR01CA095419 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHEN, CHU · 2003 to 2010
$6.1M
NCI NIH HHS R01 CA095419NCI NIH HHS R01 CA 095419-01A1NIDCD NIH HHS T32 DC000018NIDCD NIH HHS T32 DC00018
6 · The paper itself

Abstract

objectiveTo validate the DNA microarray results on a subset of genes that could potentially serve as biomarkers of oral squamous cell carcinoma (OSCC) by examining their expression with an alternate quantitative method and by assessing their protein levels.

designBased on DNA microarray data from our laboratory and data reported in the literature, we identified 6 potential biomarkers of OSCC to investigate further. We used quantitative real-time polymerase chain reaction to examine expression changes of CDH11, MMP3, SPARC, POSTN, TNC, and TGM3 in OSCC and histologically normal control tissues. We further examined validated markers at the protein level by immunohistochemical analysis of OSCC tissue microarray sections.

resultsQuantitative real-time polymerase chain reaction analysis revealed upregulation of CDH11, SPARC, POSTN, and TNC gene expression and decreased TGM3 expression in OSCC tissue compared with control tissue; MMP3 was not found to be differentially expressed. In tissue microarray immunohistochemical analyses, SPARC (secreted protein, acidic, rich in cysteine), periostin, and tenascin C exhibited increased protein expression in tumor tissue compared with control tissue, and their expression was primarily localized within tumor-associated stroma rather than tumor epithelium. Conversely, transglutaminase 3 protein expression was found only within keratinocytes in control tissue and was significantly downregulated in cancer cells.

conclusionsOf 6 potential gene markers of OSCC, initially identified by DNA microarray analyses, differential expression of CDH11, SPARC, POSTN, TNC, and TGM3 were validated by quantitative real-time polymerase chain reaction. Differential expression and localization of proteins encoded by SPARC, POSTN, TNC, and TGM3 were clearly shown by tissue microarray immunohistochemical analysis.

Indexed as

Tissue Array AnalysisBiomarkers, TumorCadherinsCarcinoma, Squamous CellCase-Control StudiesCell Adhesion MoleculesCells, CulturedHumansImmunohistochemistryLinear ModelsMatrix Metalloproteinase 3Mouth NeoplasmsOligonucleotide Array Sequence AnalysisOsteonectinReproducibility of ResultsTenascinBiomarkers, TumorCadherinsCell Adhesion MoleculesMatrix Metalloproteinase 3MMP3 protein, humanosteoblast cadherinOsteonectinPOSTN protein, humanTenascinTGM3 protein, humanTransglutaminases

Identifiers

PMID18490578
PMCPMC2578846
OpenAlexW1991950013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.